Purpose and scope
This publication explains peptide and related-compound research. It does not provide individualized treatment, injection or dosing recommendations. A laboratory mechanism is not presented as a demonstrated human benefit.
The reference library is a selected set of sources, not a systematic review of all available literature. The selection and its limits should be clear on each record.
Source standards
Prefer original study reports, trial registries, official product documents and authoritative analytical references. Supplier documents may establish what a supplier lists; they are not independent efficacy evidence.
Each record should identify the studied molecule, design, population or model, route, endpoint and main limitations where the source reports them. Missing information remains missing. Human-derived cell lines are classified as cell evidence, not human trials.
Authorship and review
The byline Peptide Mag Editorial identifies editorial responsibility. A source check by an editor or an AI-assisted workflow is not an independent specialist or medical review. No such review should be implied without a named, appropriately qualified reviewer who actually performed it.
AI may assist discovery, drafting and validation. Citations, numerical claims and source interpretations must still be checked. AI must not invent contributor credentials, studies, expert review or substantive update dates.
Updates and corrections
A substantive update changes a source interpretation, a factual statement or the evidence presented. Routine navigation or formatting changes do not become a new scientific review. Corrections are described on the corrections page.
Peptide Mag and Heritage Labs USA share an owner. The ownership disclosure explains this relationship. A supplier's commercial interest does not alter the limits of an experiment.
Editorial contact
The publication's listed editorial contact is nate@peptidemag.com. Include the page URL, the disputed statement and a primary source when requesting a correction.